GLTO - Galecto, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Copenhagen,
Denmark
Type: Equity
GLTO price evolution
GLTO
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $22.86 | $21.09 | $21.46 | |
| Short term investments | $6.08 | $11.69 | ||
| Net receivables | $1.28 | $1.84 | $2.65 | $2.76 |
| Inventory | ||||
| Total current assets | $21.18 | $25.17 | $30.54 | $36.77 |
| Long term investments | ||||
| Property, plant & equipment | $0.09 | $0.14 | $0.23 | $0.33 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.13 | $1.94 | $1.45 | |
| Total investments | $6.08 | $11.69 | ||
| Total assets | $23.38 | $27.3 | $32.48 | $38.23 |
| Current liabilities | ||||
| Accounts payable | $0.5 | $0.72 | $1.67 | $1.7 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $2.44 | $3.71 | $4.32 | $5.83 |
| Long term debt | $0.07 | |||
| Total noncurrent liabilities | $0.07 | |||
| Total debt | $0.07 | |||
| Total liabilities | $2.44 | $3.71 | $4.32 | $5.9 |
| Shareholders' equity | ||||
| Retained earnings | -$270.78 | -$266.9 | -$261.56 | -$256.08 |
| Other shareholder equity | $0.66 | $0.2 | $0.33 | $0.38 |
| Total shareholder equity | $23.59 | $28.16 | $32.33 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $21.46 | $32.79 | $62.56 | $163.84 |
| Short term investments | $11.69 | $27.44 | $37.63 | |
| Net receivables | $2.76 | $2.83 | $7.85 | $3.8 |
| Inventory | ||||
| Total current assets | $36.77 | $63.91 | $110.1 | $169.29 |
| Long term investments | $5.83 | $9.05 | ||
| Property, plant & equipment | $0.33 | $1.17 | $1.04 | $0.89 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.45 | $9.28 | $12.11 | $2.3 |
| Total investments | $11.69 | $33.27 | $46.68 | |
| Total assets | $38.23 | $73.19 | $122.22 | $171.6 |
| Current liabilities | ||||
| Accounts payable | $1.7 | $3.35 | $1.53 | $2.85 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $5.83 | $11.11 | $4.54 | $5.57 |
| Long term debt | $0.07 | $0.33 | $0.45 | $0.54 |
| Total noncurrent liabilities | $0.07 | $0.33 | $0.45 | $0.54 |
| Total debt | $0.07 | $0.33 | $0.45 | $0.54 |
| Total liabilities | $5.9 | $11.44 | $4.99 | $6.11 |
| Shareholders' equity | ||||
| Retained earnings | -$256.08 | -$217.74 | -$156.11 | -$104.36 |
| Other shareholder equity | $0.38 | -$0.24 | -$0.32 | $0.67 |
| Total shareholder equity | $32.33 | $61.75 | $117.22 | $165.49 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $1.83 | $2.46 | $2.77 | |
| Selling, general & administrative | $2.77 | $3.28 | $3.18 | |
| Total operating expenses | $3.84 | $5.58 | $5.74 | $6.67 |
| Operating income | -$5.58 | -$5.74 | -$6.67 | |
| Income from continuing operations | ||||
| EBIT | -$5.3 | -$5.48 | -$6.47 | |
| Income tax expense | $0.01 | $0.04 | ||
| Interest expense | -$0.04 | |||
| Net income | ||||
| Net income | -$3.88 | -$5.34 | -$5.48 | -$6.47 |
| Income (for common shares) | -$5.34 | -$5.48 | -$6.47 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $23.77 | $48.21 | $38.49 | $24.63 |
| Selling, general & administrative | $12.69 | $13 | $13.74 | $9.01 |
| Total operating expenses | $39.91 | $61.21 | $52.23 | $33.64 |
| Operating income | -$39.91 | -$61.21 | -$52.23 | -$33.64 |
| Income from continuing operations | ||||
| EBIT | -$38.35 | -$61.62 | -$51.75 | -$34.84 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$38.35 | -$61.62 | -$51.75 | -$34.84 |
| Income (for common shares) | -$38.35 | -$61.62 | -$51.75 | -$34.84 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$5.34 | -$5.48 | -$6.47 | |
| Operating activities | ||||
| Depreciation | $0.08 | $0.1 | $0.23 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.9 | $1.36 | $1.09 | |
| Total cash flows from operations | -$4.1 | -$5.94 | -$11.47 | |
| Investing activities | ||||
| Capital expenditures | $0.08 | |||
| Investments | $6 | $5.65 | $9.5 | |
| Total cash flows from investing | $11.65 | $6 | $5.65 | $9.58 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | $0.25 | -$0.13 | -$0.09 | $0.28 |
| Change in cash and equivalents | -$1.79 | $1.9 | -$0.29 | -$1.89 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$38.35 | -$61.62 | -$51.75 | -$34.84 |
| Operating activities | ||||
| Depreciation | $0.83 | $0.49 | $0.44 | $0.19 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.43 | $5.57 | $4.48 | $0.98 |
| Total cash flows from operations | -$36.91 | -$42.93 | -$52.31 | -$38.2 |
| Investing activities | ||||
| Capital expenditures | $0.08 | -$0.2 | -$0.22 | |
| Investments | $22.25 | $12.58 | -$47.83 | |
| Total cash flows from investing | $22.33 | $12.38 | -$48.05 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.88 | $0.51 | $88.47 | |
| Net borrowings | ||||
| Total cash flows from financing | $2.88 | $0.51 | $187.39 | |
| Effect of exchange rate | $0.38 | $0.26 | -$0.92 | $3.13 |
| Change in cash and equivalents | -$11.71 | -$30.04 | -$100.36 | $149.19 |
News
Fundamentals
| Market cap | $22.29M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.25M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$21.17M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -1.05 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$16.89 |
|---|---|
| ROA | -69.78% |
| ROE | N/A |
| Debt/Equity | 0.18 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 8.68 |
| Quick ratio | N/A |